abrdn Healthcare Opportunities Fund
CIK: 0001604522
THQ
Equity
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABT Abbott Laboratories Since 2026-07-07 | 002824100 | Equity (Common) |
5.41%
|
$39.00 | 379,836 |
| 2 | ABT ABBOTT LABORATORIES Since 2026-07-07 | 002824BG4 | Debt |
1.43%
|
$10.31 | 10,498,000 |
| 3 | ABBV AbbVie Inc Since 2026-07-07 | 00287Y109 | Equity (Common) |
5.52%
|
$39.82 | 183,103 |
| 4 | ABBV ABBVIE INC Since 2026-07-07 | 00287YAW9 | Debt |
0.37%
|
$2.64 | 3,080,000 |
| 5 | ABBV ABBVIE INC Since 2026-07-07 | 00287YBF5 | Debt |
0.74%
|
$5.32 | 5,303,000 |
| 6 | ALHC Alignment Healthcare Inc Since 2026-07-07 | 01625V104 | Equity (Common) |
1.01%
|
$7.28 | 413,043 |
| 7 | AMGN AMGEN INC Since 2026-07-07 | 031162CZ1 | Debt |
0.34%
|
$2.42 | 2,795,000 |
| 8 | ELV Elevance Health Inc Since 2026-07-07 | 036752103 | Equity (Common) |
1.99%
|
$14.32 | 48,927 |
| 9 | ELV ELEVANCE HEALTH INC Since 2026-07-07 | 036752AG8 | Debt |
0.41%
|
$2.96 | 2,975,000 |
| 10 | ELV ELEVANCE HEALTH INC Since 2026-07-07 | 036752AP8 | Debt |
0.73%
|
$5.23 | 5,800,000 |
| 11 | RCUS Arcus Biosciences Inc Since 2026-07-07 | 03969F109 | Equity (Common) |
0.80%
|
$5.75 | 266,041 |
| 12 | AZN ASTRAZENECA PLC Since 2026-07-07 | 046353AD0 | Debt |
0.74%
|
$5.31 | 4,750,000 |
| 13 | BCRX BioCryst Pharmaceuticals Inc Since 2026-07-07 | 09058V103 | Equity (Common) |
2.59%
|
$18.67 | 1,960,732 |
| 14 | BDSX Biodesix Inc Since 2026-07-07 | 09075X207 | Equity (Common) |
0.92%
|
$6.65 | 458,438 |
| 15 | CDNA CareDx Inc Since 2026-07-07 | 14167L103 | Equity (Common) |
0.60%
|
$4.33 | 249,222 |
| 16 | CRL Charles River Laboratories International Inc Since 2026-07-07 | 159864107 | Equity (Common) |
0.93%
|
$6.72 | 38,966 |
| 17 | DXCM Dexcom Inc Since 2026-07-07 | 252131107 | Equity (Common) |
0.76%
|
$5.48 | 87,236 |
| 18 | IRON Disc Medicine Inc Since 2026-07-07 | 254604101 | Equity (Common) |
0.76%
|
$5.51 | 86,107 |
| 19 | DHC Diversified Healthcare Trust Since 2026-07-07 | 25525P107 | Equity (Common) |
0.27%
|
$1.95 | 293,879 |
| 20 | GEHC GE HealthCare Technologies Inc Since 2026-07-07 | 36266G107 | Equity (Common) |
1.60%
|
$11.52 | 161,860 |
| 21 | HCA HCA Healthcare Inc Since 2026-07-07 | 40412C101 | Equity (Common) |
0.37%
|
$2.68 | 5,667 |
| 22 | DOC Healthpeak Properties Inc Since 2026-07-07 | 42250P103 | Equity (Common) |
1.22%
|
$8.78 | 534,110 |
| 23 | HUM Humana Inc Since 2026-07-07 | 444859102 | Equity (Common) |
1.17%
|
$8.47 | 48,838 |
| 24 | INSP Inspire Medical Systems Inc Since 2026-07-07 | 457730109 | Equity (Common) |
1.45%
|
$10.49 | 203,308 |
| 25 | NSPR InspireMD Inc Since 2026-07-07 | 45779A846 | Equity (Common) |
0.24%
|
$1.73 | 1,059,385 |
| 26 | ISRG Intuitive Surgical Inc Since 2026-07-07 | 46120E602 | Equity (Common) |
4.09%
|
$29.54 | 64,078 |
| 27 | IQV IQVIA Holdings Inc Since 2026-07-07 | 46266C105 | Equity (Common) |
0.73%
|
$5.29 | 31,042 |
| 28 | JNJ JOHNSON & JOHNSON Since 2026-07-07 | 478160BV5 | Debt |
1.12%
|
$8.05 | 10,130,000 |
| 29 | LTC LTC Properties Inc Since 2026-07-07 | 502175102 | Equity (Common) |
0.72%
|
$5.18 | 139,352 |
| 30 | LUCD Lucid Diagnostics Inc Since 2026-07-07 | 54948X109 | Equity (Common) |
0.58%
|
$4.19 | 3,644,277 |
| 31 | MRK Merck & Co Inc Since 2026-07-07 | 58933Y105 | Equity (Common) |
6.96%
|
$50.19 | 417,254 |
| 32 | MRK MERCK & CO INC Since 2026-07-07 | 58933YAX3 | Debt |
0.54%
|
$3.92 | 4,000,000 |
| 33 | MOH Molina Healthcare Inc Since 2026-07-07 | 60855R100 | Equity (Common) |
1.03%
|
$7.40 | 55,522 |
| 34 | MYGN Myriad Genetics Inc Since 2026-07-07 | 62855J104 | Equity (Common) |
0.69%
|
$5.00 | 1,110,404 |
| 35 | NHI National Health Investors Inc Since 2026-07-07 | 63633D104 | Equity (Common) |
0.06%
|
$0.45 | 5,596 |
| 36 | NEO NeoGenomics Inc Since 2026-07-07 | 64049M209 | Equity (Common) |
1.15%
|
$8.33 | 1,122,042 |
| 37 | OHI Omega Healthcare Investors Inc Since 2026-07-07 | 681936100 | Equity (Common) |
1.81%
|
$13.05 | 297,889 |
| 38 | PFE PFIZER INC Since 2026-07-07 | 717081EC3 | Debt |
0.41%
|
$2.95 | 3,200,000 |
| 39 | PFE PFIZER INC Since 2026-07-07 | 717081ET6 | Debt |
1.10%
|
$7.96 | 8,100,000 |
| 40 | PRAX Praxis Precision Medicines Inc Since 2026-07-07 | 74006W207 | Equity (Common) |
2.00%
|
$14.42 | 44,768 |
| 41 | REGN Regeneron Pharmaceuticals Inc Since 2026-07-07 | 75886F107 | Equity (Common) |
0.70%
|
$5.07 | 6,564 |
| 42 | SBRA Sabra Health Care REIT Inc Since 2026-07-07 | 78573L106 | Equity (Common) |
1.41%
|
$10.20 | 530,480 |
| 43 | SRPT Sarepta Therapeutics Inc Since 2026-07-07 | 803607100 | Equity (Common) |
2.90%
|
$20.91 | 961,017 |
| 44 | WGS GeneDx Holdings Corp Since 2026-07-07 | 81663L200 | Equity (Common) |
0.83%
|
$5.96 | 92,816 |
| 45 | SERA Sera Prognostics Inc Since 2026-07-07 | 81749D107 | Equity (Common) |
0.35%
|
$2.55 | 1,254,982 |
| 46 | SPRY ARS Pharmaceuticals Inc Since 2026-07-07 | 82835W108 | Equity (Common) |
1.99%
|
$14.32 | 1,783,628 |
| 47 | SGP SpyGlass Pharma Inc Since 2026-07-07 | 85220G109 | Equity (Common) |
0.24%
|
$1.75 | 67,379 |
| 48 | TNDM Tandem Diabetes Care Inc Since 2026-07-07 | 875372203 | Equity (Common) |
0.39%
|
$2.79 | 145,766 |
| 49 | TMO Thermo Fisher Scientific Inc Since 2026-07-07 | 883556102 | Equity (Common) |
4.02%
|
$28.97 | 58,943 |
| 50 | TMO THERMO FISHER SCIENTIFIC Since 2026-07-07 | 883556CY6 | Debt |
0.89%
|
$6.42 | 6,500,000 |
| 51 | PCVX Vaxcyte Inc Since 2026-07-07 | 92243G108 | Equity (Common) |
0.44%
|
$3.18 | 54,750 |
| 52 | VTR Ventas Inc Since 2026-07-07 | 92276F100 | Equity (Common) |
1.38%
|
$9.92 | 121,336 |
| 53 | ELV ELEVANCE HEALTH INC Since 2026-07-07 | 94973VBK2 | Debt |
0.28%
|
$1.99 | 2,325,000 |
| 54 | WELL Welltower Inc Since 2026-07-07 | 95040Q104 | Equity (Common) |
1.59%
|
$11.45 | 57,915 |
| 55 | ZBH ZIMMER BIOMET HOLDINGS Since 2026-07-07 | 98956PAG7 | Debt |
0.77%
|
$5.55 | 6,000,000 |
| 56 | ZTS Zoetis Inc Since 2026-07-07 | 98978V103 | Equity (Common) |
3.10%
|
$22.40 | 189,493 |
| 57 | MDT Medtronic PLC Since 2026-07-07 | — | Equity (Common) |
4.22%
|
$30.44 | 351,290 |
| 58 | PCSC Perceptive Capital Solutions Corp Since 2026-07-07 | — | Equity (Common) |
0.54%
|
$3.90 | 355,447 |
| 59 | OCS Oculis Holding AG Since 2026-07-07 | — | Equity (Common) |
2.10%
|
$15.15 | 569,796 |
Frequently Asked Questions — abrdn Healthcare Opportunities Fund
What type of mutual fund is abrdn Healthcare Opportunities Fund?
abrdn Healthcare Opportunities Fund is a SEC-registered Equity fund, with $721M in assets under management.
Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate.
As of its latest SEC N-PORT filing, abrdn Healthcare Opportunities Fund holds 59 portfolio positions, all detailed in the holdings table on this page.
What are abrdn Healthcare Opportunities Fund's assets under management (AUM)?
abrdn Healthcare Opportunities Fund has $721M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting.
AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale.
AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are abrdn Healthcare Opportunities Fund's top holdings?
According to abrdn Healthcare Opportunities Fund's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include
Abbott Laboratories,
ABBOTT LABORATORIES,
AbbVie Inc
, among others.
The complete list of all 59 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above.
Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is abrdn Healthcare Opportunities Fund's expense ratio?
Expense ratio data for abrdn Healthcare Opportunities Fund is not currently available in StockSifting's database.
The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors.
For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find abrdn Healthcare Opportunities Fund's SEC filings?
abrdn Healthcare Opportunities Fund is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001604522.
You can access all of abrdn Healthcare Opportunities Fund's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on
SEC EDGAR (CIK: 0001604522).
N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is abrdn Healthcare Opportunities Fund's holdings data on StockSifting?
Holdings data for abrdn Healthcare Opportunities Fund on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing.
Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions.
The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released.
For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.